Variant report
Variant | rs10484431 |
---|---|
Chromosome Location | chr6:25926674-25926675 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TRIM38-4 | chr6:25926123-25926754 | NONHSAT108193 |
No data |
No data |
Variant related genes | Relation type |
---|---|
SLC17A2 | TF binding region |
ENSG00000112337 | Chromatin interaction |
ENSG00000180596 | Chromatin interaction |
ENSG00000180573 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10484434 | 0.87[CHD][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap] |
rs11751732 | 1.00[JPT][hapmap] |
rs11755492 | 1.00[JPT][hapmap];1.00[YRI][hapmap] |
rs11757088 | 1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap] |
rs11757800 | 0.96[ASN][1000 genomes] |
rs11758372 | 1.00[CHB][hapmap];0.87[CHD][hapmap];1.00[JPT][hapmap];0.90[MEX][hapmap];1.00[YRI][hapmap] |
rs11759668 | 1.00[JPT][hapmap] |
rs11964886 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.87[ASN][1000 genomes] |
rs11969868 | 1.00[CHB][hapmap];0.87[CHD][hapmap];0.90[GIH][hapmap];1.00[JPT][hapmap];0.81[ASN][1000 genomes] |
rs1408269 | 0.96[ASN][1000 genomes] |
rs16891142 | 1.00[CEU][hapmap];1.00[JPT][hapmap];0.95[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs16891146 | 0.97[EUR][1000 genomes] |
rs17320614 | 1.00[JPT][hapmap] |
rs17596719 | 1.00[JPT][hapmap];1.00[YRI][hapmap] |
rs1800758 | 1.00[CHB][hapmap] |
rs185635 | 1.00[JPT][hapmap] |
rs199729 | 1.00[JPT][hapmap] |
rs199738 | 1.00[JPT][hapmap] |
rs2051538 | 1.00[JPT][hapmap] |
rs2071302 | 1.00[JPT][hapmap] |
rs2181802 | 1.00[YRI][hapmap] |
rs2230654 | 1.00[JPT][hapmap] |
rs2275906 | 1.00[CHB][hapmap];1.00[JPT][hapmap] |
rs3734524 | 1.00[JPT][hapmap] |
rs3884392 | 1.00[ASN][1000 genomes] |
rs4343909 | 1.00[JPT][hapmap] |
rs62392761 | 0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62394317 | 0.96[ASN][1000 genomes] |
rs62394320 | 0.94[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs6456704 | 0.93[ASN][1000 genomes] |
rs6906460 | 1.00[JPT][hapmap] |
rs6925912 | 1.00[JPT][hapmap] |
rs72843532 | 0.83[ASN][1000 genomes] |
rs72843536 | 0.83[ASN][1000 genomes] |
rs7746105 | 1.00[JPT][hapmap];0.80[MEX][hapmap] |
rs7757646 | 1.00[JPT][hapmap] |
rs7775820 | 1.00[JPT][hapmap] |
rs9689245 | 1.00[JPT][hapmap] |
rs9885831 | 1.00[JPT][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1029920 | chr6:25638507-26585842 | Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Active TSS Genic enhancers Strong transcription Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 1215 gene(s) | inside rSNPs | diseases |
2 | nsv538162 | chr6:25638507-26585842 | Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Weak transcription Strong transcription Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 1215 gene(s) | inside rSNPs | diseases |
3 | nsv1030351 | chr6:25813178-26352046 | Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 1189 gene(s) | inside rSNPs | diseases |
4 | nsv1023453 | chr6:25853830-26528250 | Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Strong transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 1201 gene(s) | inside rSNPs | diseases |
5 | nsv1025237 | chr6:25874326-26280867 | Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent/Poised TSS Strong transcription Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 1166 gene(s) | inside rSNPs | diseases |
6 | nsv538163 | chr6:25874326-26280867 | Enhancers Flanking Active TSS Strong transcription Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 1166 gene(s) | inside rSNPs | diseases |
7 | nsv5229 | chr6:25912151-25956558 | Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Active TSS Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
8 | esv2755446 | chr6:25924513-25981648 | Weak transcription Genic enhancers Active TSS Strong transcription Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 15 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:25923200-25927800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr6:25924600-25927200 | Weak transcription | HepG2 | liver |
3 | chr6:25926000-25927400 | Enhancers | Liver | Liver |
4 | chr6:25926200-25928000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr6:25926600-25927000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |